Genentech Statement on Hemlibra Supply Amid 2019-nCoV (Novel Coronavirus)

Industry News
Genentech has issued the following statement regarding the supply and availability of Hemlibra in the wake of the 2019-nCoV (novel coronavirus) outbreak:
Please note that HFA does not recommend, endorse or make any representation about the efficacy, appropriateness or suitability of any specific products, treatments, or opinions. If you have any questions or concerns about your medical treatment, please consult your physician.